Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4110-4111. doi: 10.1007/s00259-023-06335-9. Epub 2023 Jul 15.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37452871
Free PMC article.
No abstract available.
Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates.
Fani M, Weingaertner V, Kolenc Peitl P, Mansi R, Gaonkar RH, Garnuszek P, Mikolajczak R, Novak D, Simoncic U, Hubalewska-Dydejczyk A, Rangger C, Kaeopookum P, Decristoforo C.
Fani M, et al.
Pharmaceuticals (Basel). 2020 Dec 28;14(1):19. doi: 10.3390/ph14010019.
Pharmaceuticals (Basel). 2020.
PMID: 33379299
Free PMC article.
Item in Clipboard
Cite
Cite